Increased cell surface free thiols identify effector CD8+ T cells undergoing T cell receptor stimulation.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 3827480)

Published in PLoS One on November 13, 2013

Authors

Samuel Troy Pellom1, Ryan D Michalek, Katie E Crump, P Kent Langston, Daniel G Juneau, Jason M Grayson

Author Affiliations

1: Laboratory of Lymphocyte Function, Meharry Medical College, Nashville, Tennessee, United States of America.

Articles cited by this

Restoring function in exhausted CD8 T cells during chronic viral infection. Nature (2005) 28.04

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity (1998) 17.27

Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol (2003) 15.51

Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity (2007) 12.98

Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol (2003) 11.48

Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med (1984) 10.66

Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity (2010) 4.06

Inflammatory cytokines as a third signal for T cell activation. Curr Opin Immunol (2010) 2.44

Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc Natl Acad Sci U S A (2002) 2.35

Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo. J Immunol (2002) 2.26

Generation of effector CD8+ T cells and their conversion to memory T cells. Immunol Rev (2010) 1.85

T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc Natl Acad Sci U S A (2006) 1.63

Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation. J Immunol (1986) 1.58

Lymphocyte surface thiol levels. Proc Natl Acad Sci U S A (2003) 1.52

The mechanism of cell-mediated cytotoxicity. I. Killing by murine cytotoxic T lymphocytes requires cell surface thiols and activated proteases. J Immunol (1980) 1.45

The requirement of reversible cysteine sulfenic acid formation for T cell activation and function. J Immunol (2007) 1.41

Receptor-stimulated oxidation of SHP-2 promotes T-cell adhesion through SLP-76-ADAP. EMBO J (2005) 1.36

Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition. Immunity (2009) 1.22

NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. Eur J Immunol (2000) 1.21

Redox regulation of surface protein thiols: identification of integrin alpha-4 as a molecular target by using redox proteomics. Proc Natl Acad Sci U S A (2003) 1.11

Mitochondrial potential and reactive oxygen intermediates in antigen-specific CD8+ T cells during viral infection. J Immunol (2003) 1.05

On the lifespan of virgin T lymphocytes. J Immunol (1999) 1.01

Surface thiols of human lymphocytes and their changes after in vitro and in vivo activation. J Leukoc Biol (1996) 1.00

Sulfhydryl oxidation down-regulates T-cell signaling and inhibits tyrosine phosphorylation of phospholipase C gamma 1. Proc Natl Acad Sci U S A (1992) 0.99

T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules. Cytokine (2011) 0.92

The reversible formation of cysteine sulfenic acid promotes B-cell activation and proliferation. Eur J Immunol (2012) 0.87

Modulation of human T cell functions by surface sulphydryl groups: differential effects on IL-2 production and responsiveness. Clin Exp Immunol (1992) 0.81

Articles by these authors

Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med (2003) 3.68

Metabolic regulation of T lymphocytes. Annu Rev Immunol (2013) 3.67

Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction. Immunity (2008) 2.26

The requirement of reversible cysteine sulfenic acid formation for T cell activation and function. J Immunol (2007) 1.41

Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Arterioscler Thromb Vasc Biol (2009) 1.38

Landscape of the mitochondrial Hsp90 metabolome in tumours. Nat Commun (2013) 1.29

Activation of Tyk2 and Stat3 is required for the apoptotic actions of interferon-beta in primary pro-B cells. J Biol Chem (2006) 1.23

IL-7 is essential for homeostatic control of T cell metabolism in vivo. J Immunol (2010) 1.22

The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus. Biochem Biophys Res Commun (2009) 1.19

Electron transport complex I is required for CD8+ T cell function. J Immunol (2006) 1.17

Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice. J Biol Chem (2010) 1.17

Antioxidant treatment reduces expansion and contraction of antigen-specific CD8+ T cells during primary but not secondary viral infection. J Virol (2004) 1.05

Metabolomic profiles and childhood obesity. Obesity (Silver Spring) (2014) 1.00

The oxysterol, 27-hydroxycholesterol, links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors. Endocrinology (2011) 0.96

Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88. J Immunol (2011) 0.93

Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T cells. Cancer Res (2012) 0.91

Apoptosis induction and interferon signaling but not IFN-beta promoter induction by an SV5 P/V mutant are rescued by coinfection with wild-type SV5. Virology (2003) 0.88

Differential regulation of primary and memory CD8 T cell immune responses by diacylglycerol kinases. J Immunol (2012) 0.88

The reversible formation of cysteine sulfenic acid promotes B-cell activation and proliferation. Eur J Immunol (2012) 0.87

The roles of IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: Insights from a DC vaccination model. Cell Immunol (2010) 0.86

Changes in functional but not structural avidity during differentiation of CD8+ effector cells in vivo after virus infection. J Immunol (2012) 0.83

Genetic characterization and role in virulence of the ribonucleotide reductases of Streptococcus sanguinis. J Biol Chem (2013) 0.82

Antioxidant treatment regulates the humoral immune response during acute viral infection. J Virol (2012) 0.79

Mnk1 and 2 are dispensable for T cell development and activation but important for the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol (2012) 0.79

Defects in apoptosis increase memory CD8+ T cells following infection of Bim-/-Faslpr/lpr mice. Cell Immunol (2011) 0.78

The requirement of reactive oxygen intermediates for lymphocytic choriomeningitis virus binding and growth. Virology (2008) 0.77

Peroxiredoxin II regulates effector and secondary memory CD8+ T cell responses. J Virol (2012) 0.76

Corrigendum: Landscape of the mitochondrial Hsp90 metabolome in tumours. Nat Commun (2015) 0.75